Skip to main content
. 2023 Apr 18;55(1):2199219. doi: 10.1080/07853890.2023.2199219

Figure 1.

Figure 1.

Recurrence-free survival (RFS) of hepatocellular carcinoma patients after hepatic resection (HR) alone or with postoperative adjuvant transarterial chemoembolization (PA-TACE): comparison of RFS (A) among total patients (n = 749), (B) in the matched Early recurrence group (n = 170), (C) in the matched Not early recurrence group (n = 170). The log-rank test was used to determine significant differences between Kaplan–Meier curves.